Skip to main content
OpenTrials
Completed

NCT Number: NCT05851833

A Retrospective Study of Early Postoperative Mobilization in the Recovery of Patients With Oral Head and Neck Tumors Who Underwent Flap Reconstruction

All patients with head and neck cancers and osteomyelitis who underwent vascularized flap reconstruction at Shanghai Ninth People's Hospital (North Campus), Shanghai Jiao Tong University, from February 2020 to July 2021 were the object of a retrospective data collection.Depending on whether they had postoperative early mobilization, all patients were split into experimental and control groups.In the experimental group, patients were split into two groups based on the postoperative day(POD): the POD 0-1 group and the POD >1 group.Comparison and analysis were done on the difference in hospital days and post-operative complication rates between the two groups.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Shanghai Ninth People's Hospital

Shanghai, Shanghai Municipality, 200000, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with head and neck diseases undergoing flap reconstruction and repair
  • Patients with complete data preservation and consent
  • Patients who follow medical advice during hospitalization

Exclusion criteria

  • Patients who survived less than 1 month after surgery
  • Patients with other tumors before surgery 3, mental patients, audio-visual impairment or uncooperative patients

Treatment and study plan

Early mobilization

Behavioral

The time the patient began to sit, stand, and walk after surgery is earlier than traditional model.

Primary outcomes

  1. Length of hospital stay after surgery

    Time frame: February 2020 to July 2021

    The time span between the end of surgery and hospital discharge is defined as the length of hospital stay after surgery.

Secondary outcomes

  1. pulmonary infection rate

    Time frame: February 2020 to July 2021

    The pulmonary infection rate is calculated as the proportion of hospitalized patients who had pulmonary infections over all patients.

  2. deep vein thrombosis rate

    Time frame: February 2020 to July 2021

    The deep vein thrombosis rate is calculated as the proportion of hospitalized patients who had deep vein thrombosis over all patients.

  3. flap crisis rate

    Time frame: February 2020 to July 2021

    The flap crisis rate is calculated as the proportion of hospitalized patients who had flap crisis over all patients.

Sponsors and collaborators

Lead sponsor

Jie He, MD

Other

Registry information

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
May 10, 2023
Registry last updated
May 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.